Determining accurate costs for genomic sequencing technologies—a necessary prerequisite

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

You may have access to this PDF.

Abstract

Genome sequencing (GS) is increasingly being translated into clinical practice and is a technology characterized by a complex multi-step workflow. Funding decisions for GS would be aided by formal economic evaluation of GS platforms, but these analyses require detailed costing. This article addresses the importance of and challenges associated with costing GS using a GS microcosting project in autism spectrum disorder as an illustrative example.

Cite

CITATION STYLE

APA

Jegathisawaran, J., Tsiplova, K., Hayeems, R., & Ungar, W. J. (2020). Determining accurate costs for genomic sequencing technologies—a necessary prerequisite. Journal of Community Genetics, 11(2), 235–238. https://doi.org/10.1007/s12687-019-00442-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free